累及三叉神经的肿瘤术后三叉神经病变的转归与结局观察
前瞻性观察性研究纳入2018年10月至2019年2月术中确认累及三叉神经的25例肿瘤患者,记录术前及术后三叉神经功能状态。结果显示术后三叉神经病变发生率高且恢复不佳,脑膜瘤患者术后全部出现面部感觉异常,神经鞘瘤患者面干眼症发生率达85.7%。作者认为当三叉神经损伤不可避免时,应进行多学科细致随访和积极管理。
要点
- 脑膜瘤患者术后全部出现面部感觉异常,94.4%主诉眼干。
- 神经鞘瘤患者术后85.7%出现面部感觉异常和眼干。
- 随访中脑膜瘤患者面部感觉异常改善率为50.0%,神经鞘瘤为66.7%。
核心结论
- 累及三叉神经的肿瘤术后三叉神经病变是常见并发症,发生率高且恢复结局不佳。
- 当三叉神经损伤不可避免时,提供多学科细致随访和积极管理策略以减少术后三叉神经病变更严重的影响是必要的。
研究设计与样本
- 前瞻性观察性研究,于2018年10月至2019年2月纳入25例由资深作者术中确认累及三叉神经的肿瘤患者,记录术前和术后三叉神经功能状态及临床数据。
- 纳入病例包括18例脑膜瘤和7例三叉神经鞘瘤。
主要发现
- 脑膜瘤患者术前55.6%报告面部感觉功能障碍,33.3%出现眼部不适,5.6%有咀嚼肌萎缩。
- 脑膜瘤患者术后全部出现面部感觉异常,94.4%主诉眼干,1例(5.56%)出现角膜炎,1例(5.56%)新发咀嚼无力。
- 脑膜瘤随访中50.0%患者面部感觉异常改善,1例(5.56%)恶化,眼干在35.3%患者中缓解,1例角膜炎缓解,但1例(5.56%)新发神经营养性角膜炎,55.6%患者表现为轻度咀嚼无力但无肌肉萎缩。
- 神经鞘瘤患者术前28.6%有面部感觉异常,42.9%有眼部不适,1例(14.3%)主诉咀嚼功能障碍。
- 神经鞘瘤患者术后85.7%报告面部感觉异常和眼干,1例(16.7%)出现角膜炎;随访中66.7%面部感觉异常改善,28.6%眼干缓解,1例(16.7%)角膜炎恢复,但1例(16.7%)新发神经营养性角膜炎,1例(16.7%)咀嚼功能障碍缓解,42.9%报告轻度恶化,另1例(14.3%)面部麻木未改善。
临床怎么用
- 作者认为当三叉神经损伤不可避免时,提供多学科细致随访和积极管理策略是必要的,以减少术后三叉神经病变更严重的影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To observe the evolution and outcomes of postoperative trigeminal neuropathy following surgery of tumor involving the trigeminal nerve. METHODS: A prospective observational study was conducted between October 2018 and February 2019 involving 25 patients with tumors confirmed to involve the trigeminal nerve during surgery by senior author. Pre- and postoperative trigeminal nerve function status and clinical data were recorded. RESULTS: This study included 18 cases of meningioma and seven of trigeminal schwannoma. Among the meningioma cases, 55.6% of the patients reported facial sensory dysfunction before surgery, 33.3% presented ocular discomfort, and 5.6% had masticatory muscle atrophy. Postoperatively, all patients experienced facial paresthesia, 94.4% complained of eye dryness, and one (5.56%) exhibited keratitis. Additionally, one patient (5.56%) showed new-onset masticatory weakness. During follow-up, 50.0% of patients reported improvement in facial paresthesia, and one (5.56%) experienced deterioration. Eye dryness resolved in 35.3% of patients, and keratitis remission was observed in one patient. However, one patient (5.56%) developed neurotrophic keratitis. Overall, 55.6% of patients displayed mild masticatory weakness without muscle atrophy. In the cases of schwannoma, 28.6% of patients had facial paresthesia before surgery, 42.9% showed ocular discomfort, and one (14.3%) complained of masticatory dysfunction. Postoperatively, 85.7% of patients reported facial paresthesia and eye dryness, with one patient (16.7%) experiencing keratitis. During follow-up, 66.7% of patients demonstrated improvement in facial paresthesia, 28.6% showed eye dryness remission, and one patient (16.7%) recovered from keratitis. However, one patient (16.7%) developed new-onset neurotrophic keratitis. One patient (16.7%) experienced relief of masticatory dysfunction, but 42.9% reported mild deterioration. Another patient (14.3%) had facial anesthesia that had not improved. CONCLUSION: Postoperative trigeminal neuropathy is a common complication with a high incidence rate and poor recovery outcomes after surgery for tumors involving the trigeminal nerve. When trigeminal nerve damage is unavoidable, it is essential to provide a multidisciplinary and careful follow-up, along with active management strategy, to mitigate the more severe effects of postoperative trigeminal neuropathy.
引用
- Chen LP, Li D, Li XJ, et al. Postoperative trigeminal neuropathy outcomes following surgery for tumors involving the trigeminal nerve. Acta Neurochir (Wien). 2023. PMID: 37581723. doi:10.1007/s00701-023-05735-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。